Formulation and evaluation of macrophage targeted amphotericin b and miltefosine combination nanovesicles for the treatment of visceral leishmaniasis

dc.contributor.guide	Ramana Murthy, K. V.
dc.coverage.spatial
dc.creator.researcher	Mulugeta Fentie Bezabeh
dc.date.accessioned	2022-07-25T05:09:01Z
dc.date.available	2022-07-25T05:09:01Z
dc.date.awarded	2022
dc.date.completed	2021
dc.date.registered
dc.description.abstract	None
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	ix, 122p.
dc.identifier.uri	http://hdl.handle.net/10603/395063
dc.language	English
dc.publisher.institution	Department of Pharmaceutical Sciences
dc.publisher.place	Vishakhapatnam
dc.publisher.university	Andhra University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	AmB-MTF
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Ethanol injection method
dc.subject.keyword	Leishmaniasis
dc.subject.keyword	Nanovesicles
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Formulation and evaluation of macrophage targeted amphotericin b and miltefosine combination nanovesicles for the treatment of visceral leishmaniasis
dc.title.alternative
dc.type.degree	Ph.D.